Granules Pharmaceuticals Inc. recalls Dextroamphetamine Saccharate
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed Impurities/Degradation Specifications:
- Products
-
- Dextroamphetamine Saccharate
- Where it was sold
-
Distributed Nationwide in the USA
Nationwide
- Units affected
- 11,928 bottles
- About this recall
- Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 30 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-034-01